164 related articles for article (PubMed ID: 9232207)
1. Antipsychotic regulation of hippocampal dopamine receptor messenger RNA expression.
Ritter LM; Meador-Woodruff JH
Biol Psychiatry; 1997 Aug; 42(3):155-64. PubMed ID: 9232207
[TBL] [Abstract][Full Text] [Related]
2. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of hippocampal AMPA and kainate receptor subunit expression by haloperidol and clozapine.
Meador-Woodruff JH; King RE; Damask SP; Bovenkerk KA
Mol Psychiatry; 1996 Mar; 1(1):41-53. PubMed ID: 9118313
[TBL] [Abstract][Full Text] [Related]
4. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.
Uezato A; Meador-Woodruff JH; McCullumsmith RE
Bipolar Disord; 2009 Nov; 11(7):711-25. PubMed ID: 19839996
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex.
Damask SP; Bovenkerk KA; de la Pena G; Hoversten KM; Peters DB; Valentine AM; Meador-Woodruff JH
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):241-9. PubMed ID: 8883957
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
Lidow MS; Goldman-Rakic PS
J Pharmacol Exp Ther; 1997 Nov; 283(2):939-46. PubMed ID: 9353417
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain.
Huang XF; Tan YY; Huang X; Wang Q
Neurosci Res; 2007 Nov; 59(3):314-21. PubMed ID: 17868938
[TBL] [Abstract][Full Text] [Related]
8. Tonic modulation of inhibition by dopamine D4 receptors in the rat hippocampus.
Romo-Parra H; Aceves J; Gutiérrez R
Hippocampus; 2005; 15(2):254-9. PubMed ID: 15476261
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time.
Taymans JM; Kia HK; Claes R; Cruz C; Leysen J; Langlois X
Eur J Neurosci; 2004 Apr; 19(8):2249-60. PubMed ID: 15090051
[TBL] [Abstract][Full Text] [Related]
10. K(v) channel interacting protein 3 expression and regulation by haloperidol in midbrain dopaminergic neurons.
Duncan CE; Schofield PR; Weickert CS
Brain Res; 2009 Dec; 1304():1-13. PubMed ID: 19781530
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of ziprasidone and haloperidol on immobilization stress-induced mRNA BDNF expression in the hippocampus and neocortex of rats.
Park SW; Lee CH; Lee JG; Lee SJ; Kim NR; Choi SM; Kim YH
J Psychiatr Res; 2009 Jan; 43(3):274-81. PubMed ID: 18656896
[TBL] [Abstract][Full Text] [Related]
12. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol.
Yu J; Källström L; Wiesel FA; Johnson AE
Synapse; 1999 Dec; 34(3):192-207. PubMed ID: 10523757
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of IEG mRNA in rat brain following acute treatment with clozapine or haloperidol: a semi-quantitative RT-PCR study.
Robbins MJ; Critchlow HM; Lloyd A; Cilia J; Clarke JD; Bond B; Jones DN; Maycox PR
J Psychopharmacol; 2008 Jul; 22(5):536-42. PubMed ID: 18208916
[TBL] [Abstract][Full Text] [Related]
15. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs.
Lidow MS; Elsworth JD; Goldman-Rakic PS
J Pharmacol Exp Ther; 1997 Apr; 281(1):597-603. PubMed ID: 9103549
[TBL] [Abstract][Full Text] [Related]
17. Effects of clozapine and haloperidol on 5-HT6 receptor mRNA levels in rat brain.
Frederick JA; Meador-Woodruff JH
Schizophr Res; 1999 Jul; 38(1):7-12. PubMed ID: 10427606
[TBL] [Abstract][Full Text] [Related]
18. Characterization of clozapine-induced changes in synaptic plasticity in the hippocampal-mPFC pathway of anesthetized rats.
Matsumoto M; Shikanai H; Togashi H; Izumi T; Kitta T; Hirata R; Yamaguchi T; Yoshioka M
Brain Res; 2008 Feb; 1195():50-5. PubMed ID: 18201687
[TBL] [Abstract][Full Text] [Related]
19. Dopamine receptor pharmacology.
Seeman P; Van Tol HH
Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
